Tributary Capital Management’s Allergan plc AGN Stock Holding History

Tributary Capital Management’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-800	Closed	-$134K	–	239
2018 Q2	$134K	Buy	+800	New	+$128K	0.01%	203
2017 Q4	–	Sell	-3,140	Closed	-$644K	–	239
2017 Q3	$644K	Sell	3,140 -50	-2%	-$11.6K	0.06%	166
2017 Q2	$775K	Sell	3,190 -120	-4%	-$28.2K	0.07%	153
2017 Q1	$791K	Sell	3,310 -300	-8%	-$69.9K	0.08%	152
2016 Q4	$758K	Sell	3,610 -200	-5%	-$41.4K	0.09%	158
2016 Q3	$877K	Hold	3,810	–	–	0.11%	157
2016 Q2	$880K	Hold	3,810	–	–	0.13%	154
2016 Q1	$1.02M	Hold	3,810	–	–	0.16%	147
2015 Q4	$1.19M	Hold	3,810	–	–	0.2%	137
2015 Q3	$1.04M	Hold	3,810	–	–	0.17%	147
2015 Q2	$1.16M	Buy	3,810 +3,000	+370%	+$895K	0.18%	143
2015 Q1	$241K	Buy	+810	New	+$231K	0.04%	176

Other funds holding AGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Tributary Capital Management's AGN Position: Q3 2018 in Review

Tributary Capital Management sold out of Allergan plc (AGN) in Q3 2018, closing a stake of 800 shares — an estimated $134K sold.

Tributary Capital Management first reported a position in AGN in Q1 2015 and held it in 12 quarters. The position peaked at $1.19M in Q4 2015. 1,067 funds tracked by Wall St. Rank hold AGN as of Q3 2018.

Tributary Capital Management reported no remaining Allergan plc position as of Q3 2018 after selling out during the quarter.
Tributary Capital Management sold 800 Allergan plc shares in Q3 2018, an estimated $134K.
Tributary Capital Management first reported a position in Allergan plc in Q1 2015 and held it in 12 quarters.
Tributary Capital Management's Allergan plc position peaked at $1.19M in Q4 2015.
1,067 funds tracked by Wall St. Rank held Allergan plc as of Q3 2018.

Based on Tributary Capital Management's 13F filing for Q3 2018, filed 16 Oct 2018.